Partner
Mike Pellini
General Partner, S32
- Firm
- S32
- Title
- General Partner
- Role
- General partner
- Known as
- Investor
Record updated 17 September 2026
About
Former CEO of Foundation Medicine, which redefined how oncologists and pharma evaluate the genomic drivers of cancer, through Roche's acquisition in 2018. Previously President and COO of Clarient, acquired by GE Healthcare. Three decades building in personalized medicine, with a particular focus on defeating cancer.
Is this you? Remove my profile